October 7, 2022 Moderna Tries to Send Message That It Owns the Commercial Rights to mRNA Technology in Suit Against Pfizer By Avi Strauss
November 19, 2021 Third Time’s the Charm: The Fate of Skinny Labels May Hang in the Balance as Teva Tries Again at the Federal Circuit By Tasos Kanopoulos
November 17, 2021 Damned If We Don’t and… Also Damned If We Don’t: A Look into the History of Vaccine Mandates and the Future of the COVID-19 Vaccine By Eleesya Cordes